{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T14:08:23Z","timestamp":1782310103759,"version":"3.54.5"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-025-04045-3","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T05:45:46Z","timestamp":1737697546000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Guillain-Barr\u00e9 syndrome in patients with multiple myeloma: three cases report and literature review"],"prefix":"10.1186","volume":"25","author":[{"given":"Zhichao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siguo","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,24]]},"reference":[{"issue":"1","key":"4045_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41572-024-00529-7","volume":"10","author":"F Malard","year":"2024","unstructured":"Malard F, Neri P, Bahlis NJ, et al. Multiple myeloma [J]. Nat Rev Dis Primers. 2024;10(1):45.","journal-title":"Nat Rev Dis Primers"},{"key":"4045_CR2","doi-asserted-by":"publisher","first-page":"102284","DOI":"10.1016\/j.ctrv.2021.102284","volume":"100","author":"P Rodriguez-Otero","year":"2021","unstructured":"Rodriguez-Otero P, Paiva B, San-Miguel JF. Roadmap to cure multiple myeloma [J]. Cancer Treat Rev. 2021;100:102284.","journal-title":"Cancer Treat Rev"},{"issue":"10280","key":"4045_CR3","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/S0140-6736(21)00517-1","volume":"397","author":"N Shahrizaila","year":"2021","unstructured":"Shahrizaila N, Lehmann HC, Kuwabara S. Guillain-Barre syndrome [J]. Lancet. 2021;397(10280):1214\u201328.","journal-title":"Lancet"},{"issue":"9","key":"4045_CR4","first-page":"CD002063","volume":"2014","author":"RA Hughes","year":"2014","unstructured":"Hughes RA, Swan AV, Van Doorn PA. Intravenous immunoglobulin for Guillain-Barre syndrome [J]. Cochrane Database Syst Rev. 2014;2014(9):CD002063.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"4045_CR5","first-page":"CD001798","volume":"2","author":"S Chevret","year":"2017","unstructured":"Chevret S, Hughes RA, Annane D. Plasma exchange for Guillain-Barre syndrome [J]. Cochrane Database Syst Rev. 2017;2(2):CD001798.","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"4045_CR6","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nrneurol.2014.121","volume":"10","author":"B Van Den Berg","year":"2014","unstructured":"Van Den Berg B, Walgaard C, Drenthen J, et al. Guillain-Barre syndrome: pathogenesis, diagnosis, treatment and prognosis [J]. Nat Rev Neurol. 2014;10(8):469\u201382.","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"4045_CR7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/jns5.12051","volume":"19","author":"SK Darweesh","year":"2014","unstructured":"Darweesh SK, Polinder S, Mulder MJ, et al. Health-related quality of life in Guillain-Barre syndrome patients: a systematic review [J]. J Peripher Nerv Syst. 2014;19(1):24\u201335.","journal-title":"J Peripher Nerv Syst"},{"key":"4045_CR8","doi-asserted-by":"crossref","unstructured":"Lu C, Hu H, Ye Y et al. Guillain-Barr Syndrome caused by Cytomegalovirus after multiple myeloma treatment [J]. Clin Lab, 2024;70(6).","DOI":"10.7754\/Clin.Lab.2024.231224"},{"issue":"2","key":"4045_CR9","first-page":"382","volume":"62","author":"I Krecak","year":"2023","unstructured":"Krecak I, Gveric-Krecak V. Refractory Guillain-Barre Syndrome in a patient with asymptomatic multiple myeloma successfully treated with low-dose rituximab [J]. Acta Clin Croat. 2023;62(2):382\u20136.","journal-title":"Acta Clin Croat"},{"issue":"5","key":"4045_CR10","doi-asserted-by":"publisher","first-page":"3064","DOI":"10.3892\/ol.2015.3634","volume":"10","author":"X Dai","year":"2015","unstructured":"Dai X, Sun X, Ni H, et al. Guillain Barre Syndrome in a multiple myeloma patient after the first course of bortezomib therapy: a case report [J]. Oncol Lett. 2015;10(5):3064\u20136.","journal-title":"Oncol Lett"},{"issue":"18","key":"4045_CR11","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.12998\/wjcc.v7.i18.2905","volume":"7","author":"YL Xu","year":"2019","unstructured":"Xu YL, Zhao WH, Tang ZY, et al. Guillain-Barre syndrome in a patient with multiple myeloma after bortezomib therapy: a case report [J]. World J Clin Cases. 2019;7(18):2905\u20139.","journal-title":"World J Clin Cases"},{"issue":"4","key":"4045_CR12","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1212\/WNL.51.4.1110","volume":"51","author":"BC Jacobs","year":"1998","unstructured":"Jacobs BC, Rothbarth PH, Van Der Meche FG, et al. The spectrum of antecedent infections in Guillain-Barre syndrome: a case-control study [J]. Neurology. 1998;51(4):1110\u20135.","journal-title":"Neurology"},{"issue":"10027","key":"4045_CR13","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/S0140-6736(16)00562-6","volume":"387","author":"VM Cao-Lormeau","year":"2016","unstructured":"Cao-Lormeau VM, Blake A, Mons S, et al. Guillain-Barre Syndrome outbreak associated with Zika virus infection in French polynesia: a case-control study [J]. Lancet. 2016;387(10027):1531\u20139.","journal-title":"Lancet"},{"issue":"2","key":"4045_CR14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nrneurol.2015.234","volume":"12","author":"HR Dalton","year":"2016","unstructured":"Dalton HR, Kamar N, Van Eijk JJ, et al. Hepatitis E virus and neurological injury [J]. Nat Rev Neurol. 2016;12(2):77\u201385.","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"4045_CR15","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/ana.24755","volume":"80","author":"PM Meyer Sauteur","year":"2016","unstructured":"Meyer Sauteur PM, Huizinga R, Tio-Gillen AP, et al. Mycoplasma pneumoniae triggering the Guillain-Barre syndrome: a case-control study [J]. Ann Neurol. 2016;80(4):566\u201380.","journal-title":"Ann Neurol"},{"issue":"20","key":"4045_CR16","doi-asserted-by":"publisher","first-page":"e2035","DOI":"10.1212\/WNL.0000000000207900","volume":"101","author":"H Bishara","year":"2023","unstructured":"Bishara H, Arbel A, Barnett-Griness O, et al. Association between Guillain-Barre Syndrome and COVID-19 infection and vaccination: a Population-based nested case-control study [J]. Neurology. 2023;101(20):e2035\u201342.","journal-title":"Neurology"},{"issue":"6","key":"4045_CR17","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/mi.2011.42","volume":"4","author":"NJ Mantis","year":"2011","unstructured":"Mantis NJ. Rediscovering IgA [J]. Mucosal Immunol. 2011;4(6):588\u20139.","journal-title":"Mucosal Immunol"},{"issue":"9","key":"4045_CR18","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1111\/j.1468-1331.2012.03730.x","volume":"19","author":"H Gensicke","year":"2012","unstructured":"Gensicke H, Datta AN, Dill P, et al. Increased incidence of Guillain-Barre syndrome after surgery [J]. Eur J Neurol. 2012;19(9):1239\u201344.","journal-title":"Eur J Neurol"},{"issue":"1","key":"4045_CR19","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12883-021-02067-1","volume":"21","author":"Q Gong","year":"2021","unstructured":"Gong Q, Liu S, Liu Y, et al. Guillain-Barre syndrome triggered by surgery in a Chinese population: a multicenter retrospective study [J]. BMC Neurol. 2021;21(1):40.","journal-title":"BMC Neurol"},{"issue":"13","key":"4045_CR20","doi-asserted-by":"publisher","first-page":"e1220","DOI":"10.1212\/WNL.0000000000006246","volume":"91","author":"J Rudant","year":"2018","unstructured":"Rudant J, Dupont A, Mikaeloff Y, et al. Surgery and risk of Guillain-Barre syndrome: a French nationwide epidemiologic study [J]. Neurology. 2018;91(13):e1220\u20137.","journal-title":"Neurology"},{"key":"4045_CR21","doi-asserted-by":"crossref","unstructured":"Tu WC, Chang ST, Huang CH et al. Guillain-Barre syndrome with respiratory failure following spine surgery for Incomplete Cervical Cord Injury: a Case Report and Literature Review [J]. Med (Kaunas), 2022;58(8).","DOI":"10.3390\/medicina58081063"},{"issue":"4","key":"4045_CR22","first-page":"CD010816","volume":"4","author":"K Scott","year":"2016","unstructured":"Scott K, Hayden PJ, Will A, et al. Bortezomib for the treatment of multiple myeloma [J]. Cochrane Database Syst Rev. 2016;4(4):CD010816.","journal-title":"Cochrane Database Syst Rev"},{"issue":"10068","key":"4045_CR23","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S0140-6736(16)31594-X","volume":"389","author":"BGM Durie","year":"2017","unstructured":"Durie BGM, Hoering A, Abidi MH, et al. Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial [J]. Lancet. 2017;389(10068):519\u201327.","journal-title":"Lancet"},{"issue":"5","key":"4045_CR24","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S1470-2045(11)70081-X","volume":"12","author":"P Moreau","year":"2011","unstructured":"Moreau P, Pylypenko H, Grosicki S, et al. Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study [J]. Lancet Oncol. 2011;12(5):431\u201340.","journal-title":"Lancet Oncol"},{"issue":"3","key":"4045_CR25","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1080\/10428194.2021.1992758","volume":"63","author":"I Vaxman","year":"2022","unstructured":"Vaxman I, Mauerman ML, Gatt ML, et al. Foot drop in patients treated with bortezomib - a case series and review of the literature [J]. Leuk Lymphoma. 2022;63(3):722\u20138.","journal-title":"Leuk Lymphoma"},{"issue":"6 Pt 2","key":"4045_CR26","doi-asserted-by":"publisher","first-page":"e193","DOI":"10.1016\/j.lpm.2013.02.328","volume":"42","author":"PA Van Doorn","year":"2013","unstructured":"Van Doorn PA. Diagnosis, treatment and prognosis of Guillain-Barre syndrome (GBS) [J]. Presse Med. 2013;42(6 Pt 2):e193\u2013201.","journal-title":"Presse Med"},{"issue":"3","key":"4045_CR27","first-page":"472","volume":"94","author":"E Muchtar","year":"2019","unstructured":"Muchtar E, Gertz MA, Kyle RA, et al. A modern primer on light chain amyloidosis in 592 patients with Mass Spectrometry-verified typing [J]. Mayo Clin Proc. 2019;94(3):472\u201383.","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"4045_CR28","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/ana.26965","volume":"96","author":"P Chompoopong","year":"2024","unstructured":"Chompoopong P, Mauermann ML, Siddiqi H, et al. Amyloid neuropathy: from pathophysiology to treatment in Light-Chain Amyloidosis and Hereditary Transthyretin amyloidosis [J]. Ann Neurol. 2024;96(3):423\u201340.","journal-title":"Ann Neurol"},{"issue":"1","key":"4045_CR29","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00277-022-05032-1","volume":"102","author":"A Brioli","year":"2023","unstructured":"Brioli A, Wyrwa A, Ruddel U, et al. Mutations in the plasma cell clone identify mechanism of polyneuropathy in a case of POEMS syndrome associated with Castleman disease and multiple myeloma [J]. Ann Hematol. 2023;102(1):239\u201342.","journal-title":"Ann Hematol"},{"issue":"22","key":"4045_CR30","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.2169\/internalmedicine.6929-20","volume":"60","author":"M Sano","year":"2021","unstructured":"Sano M, Iseki T, Sasaki M, et al. Improvement in the symptoms and VEGF levels after resection of an Extrame Dullary spinal tumor and additional chemotherapy in a patient with multiple myeloma complicated with POEMS syndrome [J]. Intern Med. 2021;60(22):3625\u201330.","journal-title":"Intern Med"},{"issue":"12","key":"4045_CR31","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1002\/ajh.27081","volume":"98","author":"A Dispenzieri","year":"2023","unstructured":"Dispenzieri A. POEMS syndrome: update on diagnosis, risk-stratification, and management [J]. Am J Hematol. 2023;98(12):1934\u201350.","journal-title":"Am J Hematol"},{"issue":"5","key":"4045_CR32","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/jnnp-2011-301706","volume":"83","author":"S Nasu","year":"2012","unstructured":"Nasu S, Misawa S, Sekiguchi Y, et al. Different neurological and physiological profiles in POEMS syndrome and chronic inflammatory demyelinating polyneuropathy [J]. J Neurol Neurosurg Psychiatry. 2012;83(5):476\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"4045_CR33","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1136\/jnnp-2020-324012","volume":"92","author":"ES Marsh","year":"2021","unstructured":"Marsh ES, Keddie S, Terris-Prestholt F, et al. Early VEGF testing in inflammatory neuropathy avoids POEMS syndrome misdiagnosis and associated costs [J]. J Neurol Neurosurg Psychiatry. 2021;92(2):172\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"4045_CR34","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1002\/ana.24951","volume":"81","author":"NP Staff","year":"2017","unstructured":"Staff NP, Grisold A, Grisold W, et al. Chemotherapy-induced peripheral neuropathy: a current review [J]. Ann Neurol. 2017;81(6):772\u201381.","journal-title":"Ann Neurol"},{"issue":"4","key":"4045_CR35","doi-asserted-by":"publisher","first-page":"612","DOI":"10.4161\/cc.27476","volume":"13","author":"C Meregalli","year":"2014","unstructured":"Meregalli C, Chiorazzi A, Carozzi VA, et al. Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy [J]. Cell Cycle. 2014;13(4):612\u201321.","journal-title":"Cell Cycle"},{"issue":"7","key":"4045_CR36","first-page":"1001","volume":"91","author":"S Gupta","year":"2006","unstructured":"Gupta S, Pagliuca A, Devereux S, et al. Life-threatening motor neurotoxicity in association with bortezomib [J]. Haematologica. 2006;91(7):1001.","journal-title":"Haematologica"},{"issue":"2","key":"4045_CR37","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1002\/acn3.706","volume":"6","author":"Z Islam","year":"2019","unstructured":"Islam Z, Papri N, Ara G, et al. Risk factors for respiratory failure in Guillain-Barre syndrome in Bangladesh: a prospective study [J]. Ann Clin Transl Neurol. 2019;6(2):324\u201332.","journal-title":"Ann Clin Transl Neurol"},{"key":"4045_CR38","doi-asserted-by":"crossref","unstructured":"Ho TW, Mishu B, Li CY et al. Guillain-Barre syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies [J]. Brain, 1995;118( Pt 3):597\u2013605.","DOI":"10.1093\/brain\/118.3.597"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04045-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-025-04045-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04045-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T05:45:53Z","timestamp":1737697553000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-025-04045-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,24]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4045"],"URL":"https:\/\/doi.org\/10.1186\/s12883-025-04045-3","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,24]]},"assertion":[{"value":"28 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval for this study was provided by Ethics Committee of Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consents for publication of the clinical details were obtained from the patients or their first-degree relatives.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36"}}